| 1 |
12698250 | Cytochrome P450 mediated-drug metabolism is reduced in children with sepsis-induced multiple organ failure. | 2003 Jun |
2 |
| 2 |
11847531 | Albendazole metabolism in patients with neurocysticercosis: antipyrine as a multifunctional marker drug of cytochrome P450. | 2002 Feb |
4 |
| 3 |
11956503 | Acute hypoxia and cytochrome P450-mediated hepatic drug metabolism in humans. | 2002 Apr |
1 |
| 4 |
10725303 | Human cytochrome P450 maximal activities in pediatric versus adult liver. | 2000 Apr |
2 |
| 5 |
8049635 | Lung tumor resection does not affect debrisoquine metabolism. | 1994 Mar |
1 |
| 6 |
2256435 | Hepatic drug metabolism is increased in poorly controlled insulin-dependent diabetes mellitus. | 1990 Nov |
1 |
| 7 |
3243660 | Phenazone pharmacokinetics as an index of hepatic metabolic efficiency. | 1988 Nov |
1 |
| 8 |
3383988 | Selective inhibition of drug oxidation after simultaneous administration of two probe drugs, antipyrine and tolbutamide. | 1988 |
1 |
| 9 |
4029252 | Effect of rifampicin treatment on hepatic drug metabolism and serum bile acids in patients with primary biliary cirrhosis. | 1985 |
1 |
| 10 |
6508979 | Influence of rifampicin treatment on antipyrine clearance and metabolite formation in patients with tuberculosis. | 1984 Nov |
2 |
| 11 |
6860533 | Evidence for a dual action of sulphinpyrazone on drug metabolism in man: theophylline-sulphinpyrazone interaction. | 1983 May |
1 |
| 12 |
6946467 | Genetic variation in rates of antipyrine metabolite formation: a study in uninduced twins. | 1981 Aug |
1 |
| 13 |
7267701 | Influence of the genetically controlled deficiency in debrisoquine hydroxylation on antipyrine metabolite formation. | 1981 |
1 |
| 14 |
7341283 | Differential induction of antipyrine metabolism by rifampicin. | 1981 |
1 |
| 15 |
7450397 | Relationship between metabolic clearance rate of antipyrine and hepatic microsomal drug-oxidizing enzyme activities in humans without liver disease. | 1981 Jan |
1 |